TRPC6 and cystic fibrosis: To test the role of the TRPC6 channel in CF MDMs during roscovitine treatment, non-CF and primary CF MDMs were infected with B. cenocepacia in the presence or absence of a TRPC6 inhibitor 17 (10 μM, 4 h) and/or roscovitine or M3.